Copyright
©The Author(s) 2022.
World J Diabetes. Mar 15, 2022; 13(3): 150-160
Published online Mar 15, 2022. doi: 10.4239/wjd.v13.i3.150
Published online Mar 15, 2022. doi: 10.4239/wjd.v13.i3.150
Figure 3 The gut microbiota could contribute to the favorable production of short-chain fatty acids, reactive oxygen species and D-amino acids against progression of diabetic nephropathy.
Fecal microbiota transplantation consists of fecal microbiota infusion from a healthy donor to a recipient, which has been likely more successful than conventional therapy for diabetic nephropathy. Note that some critical events such as cytokine-induction have been omitted for clarity. SCFAs: Short-chain fatty acids; ROS: Reactive oxygen species; DN: Diabetic nephropathy; DM: Diabetes mellitus.
- Citation: Nagase N, Ikeda Y, Tsuji A, Kitagishi Y, Matsuda S. Efficacy of probiotics on the modulation of gut microbiota in the treatment of diabetic nephropathy. World J Diabetes 2022; 13(3): 150-160
- URL: https://www.wjgnet.com/1948-9358/full/v13/i3/150.htm
- DOI: https://dx.doi.org/10.4239/wjd.v13.i3.150